The combination of biological innovation and pharmaceutical muscle could create a unique pathway for translating microbiome discoveries into accessible, science-backed solutions for everyday health.
Specific gut bacteria are important in early life for healthy immune development.
Dietary LPS can mimic microbial signals and drive gut immune development, with early-life being a critical window for shaping gut immunity.
Dietary intervention and the utilization of D. dubosii offer potential insights for the treatment of brain tumor patients.
The findings of a recent study highlight the importance of understanding skin microbiotas to manage long-term fungal infections in Indigenous communities.
The gut microbiome has emerged not just as a passive bystander in sports, but as an active modulator of athletic energy, recovery, and resilience.
New funding boosts development of microbiome-based therapies for hereditary cancer risk, opening paths to alternatives beyond surgery.
STING activity is important for gut health and that targeting this molecule could offer new treatments for IBD.
The Bill & Melinda Gates Foundation accelerates research and innovation targeting the most neglected areas of female health.
DQGlyco identified multiple unique N-glycopeptides, quantified glycopeptide changes, and explored the link between gut microbiome and brain protein functions.
